A novel 4-(1,3,4-thiadiazole-2-ylthio)pyrimidine derivative inhibits cell proliferation by suppressing the MEK/ERK signaling pathway in colorectal cancer
, , , , , , , e
14 set 2023
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 14 set 2023
Pagine: 489 - 502
Accettato: 18 apr 2023
DOI: https://doi.org/10.2478/acph-2023-0025
Parole chiave
© 2023 Weiwei Li et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Li, Weiwei
Department of Pharmacy, Xijing Hospital, Fourth Military Medical UniversityXi’an, China
Yang, Zhifu
Department of Pharmacy, Xijing Hospital, Fourth Military Medical UniversityXi’an, China
Ding, Likun
Department of Pharmacy, Xijing Hospital, Fourth Military Medical UniversityXi’an, China
Wang, Ying
Department of Pharmacy, The Second Affiliated Hospital of Xi’an Medical UniversityXi’an, China
Zhao, Xian
Department of Pharmacy, Xijing Hospital, Fourth Military Medical UniversityXi’an, China
Chu, Jian Jie
Department of Pharmacy, Xijing Hospital, Fourth Military Medical UniversityXi’an, China
Ji, Qing
Department of Pharmacy, Xijing Hospital, Fourth Military Medical UniversityXi’an, China
Yao, Minna
Department of Pharmacy, Xijing Hospital, Fourth Military Medical UniversityXi’an, China
Wang, Jingwen
Department of Pharmacy, Xijing Hospital, Fourth Military Medical UniversityXi’an, China